Equities are not cheap but if the penalty tariffs go into effect, then pockets of opportunity could arise. Here’s a guide on how to navigate these choppy waters
The MPC would like to assess how India’s ongoing trade tension with the US evolves
Bosch is planning to strengthen its competitive position in the mobility sector and industrial technology. It is actively adding new components, particularly those catering to EVs and advanced electronics.
The chemical business grew 24 percent YoY, helped by volume recovery in agrochemical intermediates and improved off-take for the recently launched products
The paint company is on track to gain market share despite intensifying competition
Steady ARPU growth lifts the company’s Q1 performance across India and Africa
While Q1FY26 saw some execution slippages, the company is hopeful that the next few quarters could bring better growth and margins
The upward momentum will sustain in the hotels business in FY26
The CDMO business appears steady and additional approvals of indications for the oncology drug – Darolutamide – add to revenue visibility. Further, another key contract is expected to commence from Q4 FY26
With strong execution, growing private label contribution, and a clear focus on high-return expansion, the company is structurally positioned for long-term growth in the organised fashion retail space.
Growth, margin synergies in emerging businesses will drive profitability
The bank faces the tall and arduous task of scaling up the battered business profitably
The bank’s bid to improve the asset-liability mix, along with fees, should start delivering results gradually
The company delivered a steady Q1FY26, confirming its leadership in the monetisation of entertainment IP
The company is actively pursuing market expansion by establishing strategic collaborations in sports, fashion, music, and luxury segments, and by filling product gaps with new competitive offerings, like The Spirit of Kashmyr, a luxury vodka
The company has multiple CDMO orders lined up for FY26, starting with two European majors, including US-based Fermion, for the second quarter.
Robust demand for two-wheelers power strong quarterly performance
Backward integration, improving wallet share, and new product development will be key growth drivers
FMCG growth recovery, urban demand, and stable commodity prices to aid growth, profitability
Although PV sales remained subdued, other categories offered resilience
While the near-term business performance may appear subdued, the company’s structural initiatives, such as capacity expansion and operational efficiency, are good for the long term
Sun Pharma’s top line growth is steady. Innovative medicines to act as growth tonic, as the US generics business remains soft. The stock valuation is justified.
The increasing share of LGDs in the diamond jewellery industry is beneficial for IGIL, which has established itself as leader in the segment. Leveraging this lead, IGIL is tapping new segments and consumers.
Order book is steady, while exports are showing green shoots
The car-maker needs to overcome its budget-car image while establishing credibility in the higher-margin SUV segment